Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia

PLoS ONE(2022)10.1371/journal.pone.0265278Source: DataRank Database

Performance characteristics of the first Food and Drug Administration (FDA)-cleared digital droplet PCR (ddPCR) assay for BCR::ABL1 monitoring in chronic myelogenous leukemia is a research paper published in PLoS ONE (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access18 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)OA: goldTopics (23)IDs (PubMed, PMC)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Prasanthi Bhagavatula ORCID,Nathan Sepulveda,Lan Beppu ORCID,Shital Gandhi,Dahui Qin ORCID

Live enrichment

PubMed:35298544 PMC:PMC8929598

National Institutes of Health

Grant: NIH-RO1CA 184798-04

NCI NIH HHS

Grant: R01 CA184798

National Institutes of Health

Grant: 5R01CA184798-05

Stopping Tyrosine Kinase Inhibitors in CML Patients (Stop-TKIs)

Bio-Rad Laboratories

goldLicense: cc-by

publisherhttps://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0265278&type=printable

publisherhttps://dx.plos.org/10.1371/journal.pone.0265278

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8929598

repositoryhttps://doaj.org/article/4d443c1627274a07bfe43da9290c2000

repositoryhttps://doaj.org/article/8f718335a7f54f7a832784608c190d61

Fields of Study

03 medical and health sciences0302 clinical medicine

MeSH Terms

HumansFusion Proteins, bcr-ablProtein Kinase InhibitorsReproducibility of ResultsPolymerase Chain ReactionUnited States Food and Drug AdministrationUnited StatesLeukemia, Myelogenous, Chronic, BCR-ABL Positive

Keywords

United States Food and Drug AdministrationScienceQRFusion Proteins, bcr-ablReproducibility of ResultsPolymerase Chain ReactionUnited StatesLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMedicineHumansProtein Kinase InhibitorsResearch Article

Sustainable Development Goals

SDG 3: 3. Good health